ARC Centre of Excellence in Convergent BioNano Science and Technology, Canberra Australian Capital Territory 2601, Australia.
Mol Pharm. 2017 Dec 4;14(12):4485-4497. doi: 10.1021/acs.molpharmaceut.7b00611. Epub 2017 Nov 8.
Nanoscaled polymeric materials are increasingly being investigated as pharmaceutical products, drug/gene delivery vectors, or health-monitoring devices. Surface charge is one of the dominant parameters that regulates nanomaterial behavior in vivo. In this paper, we demonstrated how control over chemical synthesis allowed manipulation of nanoparticle surface charge, which in turn greatly influenced the in vivo behavior. Three methacrylate/methacrylamide-based monomers were used to synthesize well-defined hyperbranched polymers (HBP) by reversible addition-fragmentation chain transfer (RAFT) polymerization. Each HBP had a hydrodynamic diameter of approximately 5 nm as determined by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Incorporation of a fluorescent moiety within the polymeric nanoparticles allowed determination of how charge affected the in vivo pharmacokinetic behavior of the nanomaterials and the biological response to them. A direct correlation between surface charge, cellular uptake, and cytotoxicity was observed, with cationic HBPs exhibiting higher cellular uptake and cytotoxicity than their neutral and anionic counterparts. Evaluation of the distribution of the differently charged HBPs within macrophages showed that all HBPs accumulated in the cytoplasm, but cationic HBPs also trafficked to, and accumulated within, the nucleus. Although cationic HBPs caused slight hemolysis, this was generally below accepted levels for in vivo safety. Analysis of pharmacokinetic behavior showed that cationic and anionic HBPs had short blood half-lives of 1.82 ± 0.51 and 2.34 ± 0.93 h respectively, compared with 5.99 ± 2.30 h for neutral HBPs. This was attributed to the fact that positively charged surfaces are more readily covered with opsonin proteins and thus more visible to phagocytic cells. This was supported by in vitro flow cytometric and qualitative live cell imaging studies, which showed that cationic HBPs tended to be taken up by macrophages more effectively and rapidly than neutral and anionic particles.
纳米级聚合物材料越来越多地被研究作为药物产品、药物/基因传递载体或健康监测设备。表面电荷是调节纳米材料体内行为的主要参数之一。在本文中,我们展示了如何通过控制化学合成来操纵纳米粒子的表面电荷,从而极大地影响体内行为。使用三种甲基丙烯酸酯/丙烯酰胺基单体通过可逆加成-断裂链转移(RAFT)聚合来合成具有明确支化结构的超支化聚合物(HBP)。每个 HBP 的水动力直径约为 5nm,这是通过动态光散射(DLS)和透射电子显微镜(TEM)确定的。在聚合物纳米粒子中掺入荧光部分可以确定电荷如何影响纳米材料的体内药代动力学行为以及对它们的生物学反应。观察到表面电荷、细胞摄取和细胞毒性之间存在直接相关性,阳离子 HBP 比其中性和阴离子对应物表现出更高的细胞摄取和细胞毒性。评估不同电荷的 HBP 在巨噬细胞内的分布表明,所有 HBP 都积聚在细胞质中,但阳离子 HBP 也会转运到细胞核中并在其中积聚。虽然阳离子 HBP 引起轻微的溶血,但通常低于体内安全性的可接受水平。药代动力学行为分析表明,阳离子和阴离子 HBP 的血液半衰期分别为 1.82±0.51 和 2.34±0.93 h,而中性 HBP 的半衰期为 5.99±2.30 h。这归因于带正电荷的表面更容易被调理蛋白覆盖,因此更容易被吞噬细胞识别。体外流式细胞术和定性活细胞成像研究支持了这一观点,这些研究表明阳离子 HBP 比中性和阴离子颗粒更容易被巨噬细胞有效和快速地摄取。
ACS Appl Bio Mater. 2018-9-17
Eur J Pharm Biopharm. 2013-2-16
Biomacromolecules. 2013-10-30
Nanomaterials (Basel). 2025-8-3
Materials (Basel). 2023-1-24
Cancer Cell Int. 2022-8-23
Adv Mater. 2021-3